Exact Sciences recently announced its fourth quarter numbers, which included revenues between $142.5 million – $143.5 million and 292,000 completed Cologuard tests, an increase of 64 percent and 66 percent…

Exact Sciences recently announced its third quarter numbers, which included revenue of $118.3 million and 240,000 completed Cologuard tests, an increase of 63 percent and 49 percent, respectively. “The Exact…

Exact Sciences strengthened its pipeline capabilities with its acquisition of Biomatrica, a provider of biological sample preservation technology, the company announced today. “To detect cancer at its earliest stages, you need…

Exact Sciences and Pfizer announced today an agreement to co-promote Cologuard through 2021. According to a release, Pfizer will join Exact Sciences’ sales representatives in reaching both physicians and health…

Exact Sciences broke ground on its new corporate headquarters building at University Research Park, calling it Innovation One, the company announced recently. According to a release, the 138,000 square-foot building,…

The Madison community is important to the success of Exact Sciences, CEO Kevin Conroy said at the annual shareholder meeting held today at the Edgewater Hotel. “If you have a…

Exact Sciences, along with researchers at the Mayo Clinic, announced today that they have developed a blood test that correctly identified 95 percent of the cases of a common form…

Exact Sciences named Mark Stenhouse as president of Cologuard, its noninvasive stool DNA-based test for early detection of colon cancer, the company announced recently. “More than 85 million people are…

Exact Sciences named Paul J. Limburg, M.D., M.P.H., as its co-chief medical officer, the company announced today. “Dr. Limburg’s valuable mix of cancer prevention experience in both the clinical and…

Exact Sciences’ Cologuard has been used in more than one million screenings for colorectal cancer, the company announced today. “Approximately half of Cologuard users haven’t been screened before, and we’re…